Farnesoid X receptor ‐ a molecular predictor of weight loss after vertical sleeve gastrectomy?
Summary Objective To determine the expression of the bile acid receptor, farnesoid X (FXR), in human gastric mucosa and investigate correlations between expression and body‐mass index (BMI) and in patients with obesity, with changes in weight and BMI following vertical sleeve gastrectomy (VSG). Meth...
Main Authors: | F. Scott, S. Elahi, M. Adebibe, U. Parampalli, K. Mannur, A. Góralczyk, G. J. Sanger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-06-01
|
Series: | Obesity Science & Practice |
Subjects: | |
Online Access: | https://doi.org/10.1002/osp4.337 |
Similar Items
-
MAFB mediates the therapeutic effect of sleeve gastrectomy for obese diabetes mellitus by activation of FXR expression
by: Jian Xu, et al.
Published: (2018-05-01) -
Laparoscopic sleeve gastrectomy and gastroesophageal reflux
by: Popescu Andrada-Loredana, et al.
Published: (2018-12-01) -
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
by: Insook Kim, et al.
Published: (2007-12-01) -
Vertical Sleeve Gastrectomy: Mechanisms for Weight Loss and Lessons for Obesity Therapy
by: Stefater, Margaret
Published: (2011) -
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
by: Sosmitha Girisa, et al.
Published: (2021-07-01)